Black checkmark with a sparkle and a curved line underneath on a white background.
Company

HEALTHEQUITY, INC.

Ticker
HQY
Sector
Industry
Report date
August 27, 2026
Valye AI Score

94

Very high visibility
Recent developments
Recent developments summary

Recent news coverage for HealthEquity includes pre-market earnings reports and earnings previews for Q2 2026, reflecting ongoing market interest in the company’s financial performance and key metrics.

Recent developments:
  • HealthEquity was included in a pre-market earnings report for August 27, 2026, alongside other companies, indicating market attention to its upcoming earnings release [N1].
  • Ahead of Q2 2026 earnings, Wall Street analysts provided insights and key metric expectations for HealthEquity, highlighting investor focus on the company’s financial results [N2].
  • HealthEquity was mentioned in an after-hours earnings report for May 28, 2026, showing continued coverage of its quarterly financial performance [N7].
  • Wall Street provided insights into key metrics ahead of HealthEquity’s Q1 2026 earnings, reflecting ongoing analyst engagement with the company’s results [N8].
Overview

HealthEquity, Inc. operates as a technology-enabled services company focused on empowering consumers to manage healthcare savings, spending, and investing through tax-advantaged accounts. The core product is the Health Savings Account (HSA), supplemented by other consumer-directed benefits such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA continuation coverage, and commuter benefits. The company serves consumers primarily through employer clients, benefits brokers, and a network of health plans and administrators. HealthEquity has grown its market share significantly, becoming the largest HSA provider by number of accounts and second largest by assets. Its proprietary cloud-based technology platform integrates multiple functionalities to deliver a comprehensive and personalized consumer experience. The company also offers an investment platform and advisory services to help members grow their healthcare savings. HealthEquity emphasizes a service culture and invests in technology modernization, including AI, to enhance its offerings and operational efficiency.

Executive summary

Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. HealthEquity, Inc. is a leading provider of technology-enabled services for tax-advantaged healthcare accounts, including HSAs and complementary consumer-directed benefits. The company has a strong market position with 17.8 million accounts administered as of early 2026 and a proprietary technology platform supporting integrated healthcare saving, spending, and investing. Recent SEC filings show solid liquidity and profitability for Q2 2026. The company’s business model emphasizes a bundled solution, strong distribution channels, and a service-driven culture. Recent news coverage reflects ongoing market attention to its earnings and key metrics [S1][S2][N1][N2].

Scenarios for HQY

Bull case model:

HealthEquity’s leadership position in a growing market for tax-advantaged healthcare accounts, combined with its proprietary technology platform and integrated product suite, supports strong business model visibility. The company’s broad and diversified distribution channels through network partners and direct client relationships provide scalable access to consumers. Its service culture and educational efforts may enhance member engagement and retention. The investment platform and advisory services add value and potential revenue diversification. Ongoing technology modernization, including AI integration, may improve customer experience and operational efficiency.

Bear case model:

The company faces competition from large financial institutions, healthcare service companies, and benefits administration providers with potentially greater resources. Changes in healthcare regulations or tax laws could impact the attractiveness or usage of HSAs and related products. The business depends on maintaining and expanding network partnerships and client relationships, which could be challenged by competitive offerings. Technology platform modernization carries execution risks and potential disruptions. Market dynamics and consumer behavior changes could affect account growth and usage patterns.

Moat:

HealthEquity’s moat is built on its market leadership in the HSA and complementary consumer-directed benefits space, supported by a proprietary, integrated technology platform tailored specifically for healthcare saving and spending. The company’s extensive network partnerships and direct client relationships create a broad distribution channel that is difficult to replicate. Its bundled solution offering multiple benefit types strengthens client retention and value proposition. The company’s service-driven culture and personalized member engagement further differentiate it from competitors. Continuous investment in technology modernization and AI tools enhances platform capabilities and operational efficiency, reinforcing competitive advantages.

Risks overview
Risks summary
Regulatory changes and competitive pressures represent significant risks that could materially affect HealthEquity’s business and financial performance.
Risks details:

• Regulatory and Legislative Risks: Changes in healthcare laws, tax regulations, or IRS rules could affect the eligibility, tax advantages, or usage of HSAs and other consumer-directed benefits, impacting demand for HealthEquity’s products.
• Competitive Risks: Competition from banks, financial institutions, healthcare companies, and benefits administrators with greater resources could pressure market share, pricing, and client relationships.
• Technology and Operational Risks: Risks related to the modernization of proprietary technology platforms, including AI integration, could affect service quality, security, and operational continuity.
• Market and Consumer Behavior Risks: Shifts in employer benefits offerings, consumer preferences, or economic conditions could influence account growth, member engagement, and revenue streams.

FINAL FORECAST FOR HQY

Final take one line
HealthEquity, Inc. demonstrates very high visibility through detailed SEC disclosures and extensive recent news coverage, highlighting its leadership in tax-advantaged healthcare accounts and integrated technology platform.
Final take 12 to 24 month view

Business trends: Continued growth in HSA and complementary consumer-directed benefits markets with increasing consumer responsibility for healthcare costs.
Execution milestones: Ongoing technology platform modernization including AI integration, expansion of network partnerships, and enhancement of service offerings.
Key risks: Regulatory changes affecting tax-advantaged accounts, competitive pressures from larger financial and healthcare firms, and technology execution risks.

Valye AI Visibility Research Score

Very high visibility

Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).

94
LLM visibility overview
LLM Visibility known facts
  • HealthEquity, Inc. is a technology-enabled services company focused on empowering consumers to make healthcare saving, spending, and investing decisions through tax-advantaged accounts such as Health Savings Accounts (HSAs) and other consumer-directed benefits (CDBs) including FSAs, HRAs, COBRA, and commuter benefits [S1].
  • As of January 31, 2026, HealthEquity administered 10.6 million HSAs with balances totaling $36.5 billion and 7.2 million complementary CDBs, totaling 17.8 million accounts [S1].
  • The company reaches consumers primarily through employer clients, benefits brokers and advisors, integrated partnerships with health plans, benefits administrators, retirement plan recordkeepers (Network Partners), and a direct sales force. As of January 31, 2026, platforms were integrated with over 200 Network Partners [S1].
  • HealthEquity has increased its market share in the HSA market from 4% in December 2010 to 20% as of June 2025 by HSA assets, making it the largest HSA provider by number of accounts and the second largest by assets according to the 2025 Midyear Devenir HSA Research Report [S1].
  • The company’s revenue sources include service revenue (fees from clients, network partners, and members for administration services, invested HSA assets, and marketplace revenues), custodial revenue (from HSA cash held by insurance company and bank partners), and interchange revenue (fees from merchants on payment card transactions) [S1].
  • HealthEquity offers an investment platform and an online automated investment advisory service (Advisor) through its SEC-registered subsidiary, HealthEquity Advisors, LLC, providing self-driven, guided, and fully managed investment options for members with balances above a threshold [S1].
  • The company administers healthcare FSAs, dependent care FSAs, HRAs, COBRA continuation coverage, and commuter benefit programs, providing a bundled solution for tax-advantaged healthcare and related benefits [S1].
  • HealthEquity’s proprietary cloud-based technology platform integrates multiple functionalities including custodial administration, payment processing, benefits enrollment, claims processing, medical bill presentment, investment advice, and analytics. The company is investing in modernization including AI tools to enhance security, privacy, and platform infrastructure [S1].
  • The company emphasizes a service-driven culture called 'Purple' service, focusing on customer-friendly experiences and education for members, clients, and network partners [S1].
  • HealthEquity’s business model provides strong visibility into future operating performance, with most accounts opened before the fiscal year starts [S1].
  • As of July 31, 2026, HealthEquity reported cash and equivalents of $256 million, current assets of $460 million, current liabilities of $154 million, resulting in a current ratio of 2.99 and a cash ratio of 1.66, indicating strong liquidity [S2].
  • For the quarter ended July 31, 2026, HealthEquity reported net income of $65.6 million and basic earnings per share of $0.79 [S2].
  • Recent news coverage includes pre-market earnings reports and earnings previews for Q2 2026, indicating ongoing market interest and coverage of the company’s financial performance [N1][N2][N7][N8].
Sources
Sources - Context summary

Generated 2026-08-27

Sources - Earning calls
Sources - Other context
Sources - SEC Filings
  • S1 | 2026-03-17 | 10-K
  • S2 | 2026-08-27 | 10-Q
Sources - News headlines
  • N1 | 2026-08-26 | www.nasdaq.com | Pre-Market Earnings Report for August 27, 2026 : RY, TD, CM, DG, DLTR, BURL, BBY, HRL, HQY, BILI, CSIQ, MBUU | https://www.nasdaq.com/articles/pre-market-earnings-report-august-27-2026-ry-td-cm-dg-dltr-burl-bby-hrl-hqy-bili-csiq-mbuu
  • N2 | 2026-08-24 | www.nasdaq.com | Ahead of HealthEquity (HQY) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics | https://www.nasdaq.com/articles/ahead-healthequity-hqy-q2-earnings-get-ready-wall-street-estimates-key-metrics
  • N3 | 2026-08-13 | www.nasdaq.com | Biofrontera Inc. (BFRI) Reports Q2 Loss, Beats Revenue Estimates | https://www.nasdaq.com/articles/biofrontera-inc-bfri-reports-q2-loss-beats-revenue-estimates
  • N4 | 2026-08-06 | www.nasdaq.com | Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates | https://www.nasdaq.com/articles/astrana-health-inc-asth-q2-earnings-top-estimates
  • N5 | 2026-08-06 | www.nasdaq.com | GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates | https://www.nasdaq.com/articles/goodrx-holdings-inc-gdrx-q2-earnings-match-estimates
  • N6 | 2026-07-28 | www.nasdaq.com | Can Pharmacy Wins and Home-Based Care Boost BTSG's Q2 Results? | https://www.nasdaq.com/articles/can-pharmacy-wins-and-home-based-care-boost-btsgs-q2-results
  • N7 | 2026-05-28 | www.nasdaq.com | After-Hours Earnings Report for May 28, 2026 : COST, DELL, ADSK, NTAP, MDB, OKTA, VSAT, GAP, HQY, S, ESTC, PATH | https://www.nasdaq.com/articles/after-hours-earnings-report-may-28-2026-cost-dell-adsk-ntap-mdb-okta-vsat-gap-hqy-s-estc
  • N8 | 2026-05-22 | www.nasdaq.com | Wall Street's Insights Into Key Metrics Ahead of HealthEquity (HQY) Q1 Earnings | https://www.nasdaq.com/articles/wall-streets-insights-key-metrics-ahead-healthequity-hqy-q1-earnings
Important legal disclaimer

This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Blue logo with a stylized checkmark and star above the blue text 'VALYE' on a black background.

Generated by Valye SEC Pipeline Engine